Pretax income is the income that a company earns before paying income taxes. Armata Pharmaceuticals's pretax income for the
three
months ended in Dec. 2024 was $2.60 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2024 was $-18.92 Mil.
Armata Pharmaceuticals's pretax margin was %.
During the past 13 years, Armata Pharmaceuticals's highest Pretax Margin was -124.00%. The lowest was -12295.65%. And the median was -7459.23%.
Armata Pharmaceuticals Pre-Tax Income Historical Data
The historical data trend for Armata Pharmaceuticals's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Armata Pharmaceuticals's Pre-Tax Income
For the Biotechnology subindustry, Armata Pharmaceuticals's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Armata Pharmaceuticals's Pre-Tax Income Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Armata Pharmaceuticals's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Armata Pharmaceuticals's Pre-Tax Income falls into.
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-18.92 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Armata Pharmaceuticals (AMEX:ARMP) Pre-Tax Income Explanation
Armata Pharmaceuticals's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as
During the past 13 years, Armata Pharmaceuticals's highest Pretax Margin was -124.00%. The lowest was -12295.65%. And the median was -7459.23%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Armata Pharmaceuticals Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Armata Pharmaceuticals's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ARMP has been successfully added to your 